Boston Scientific Corp. (NYSE:BSX)’s traded shares stood at 6.3 million during the last session, with the company’s beta value hitting 0.80. At the close of trading, the stock’s price was $84.73, to imply a decrease of -0.43% or -$0.37 in intraday trading. The BSX share’s 52-week high remains $88.79, putting it -4.79% down since that peak but still an impressive 41.99% since price per share fell to its 52-week low of $49.15. The company has a valuation of $124.78B, with an average of 7.44 million shares in intraday trading volume over the past 10 days and average of 5.59 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Boston Scientific Corp. (BSX), translating to a mean rating of 1.51. Of 15 analyst(s) looking at the stock, 0 analyst(s) give BSX a Sell rating. 1 of those analysts rate the stock as Overweight while 1 advise Hold as 13 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at 0.65.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Boston Scientific Corp. (NYSE:BSX) trade information
After registering a -0.43% downside in the last session, Boston Scientific Corp. (BSX) has traded red over the past five days. The 5-day price performance for the stock is -3.79%, and 1.99% over 30 days. With these gigs, the year-to-date price performance is 46.57%. Short interest in Boston Scientific Corp. (NYSE:BSX) saw shorts transact 10.92 million shares and set a 2.07 days time to cover.
The extremes give us $48 and $118 for target low and target high price respectively. As such, BSX has been trading -39.27% off suggested target high and 43.35% from its likely low.
Boston Scientific Corp. (BSX) estimates and forecasts
Looking at statistics comparing Boston Scientific Corp. share performance against respective industry, we note that the company has outperformed competitors. Boston Scientific Corp. (BSX) shares are 15.80% up over the last 6 months, with its year-to-date growth rate higher than industry average at 19.02% against 11.50%. Revenue is forecast to grow 18.20% this quarter before jumping 14.30% for the next one. The rating firms project that company’s revenue will grow 16.00% compared to the previous financial year.
Revenue forecast for the current quarter as set by 24 analysts is 4.39B. Meanwhile, for the current quarter, a total of 16 analyst(s) estimate revenue growth to 4.39B.Earnings reports from the last fiscal year show that sales brought in 3.73B and 3.86B respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 17.80% before jumping 13.80% in the following quarter.
An assessment of the company’s 5-year growth patterns shows that annual earnings shrunk an estimated -2.05% for the past 5-year period. While 2024 is set for a 19.95% return in earnings, projections for the next 5 years are at 13.00% annually.
BSX Dividends
Boston Scientific Corp. has its next earnings report out on 2025-Jan-29. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Boston Scientific Corp. (NYSE:BSX)’s Major holders
Boston Scientific Corp. insiders hold 0.18% of total outstanding shares, with institutional holders owning 92.85% of the shares at 93.03% float percentage. In total, 92.85% institutions holds shares in the company, led by FMR LLC. As of 2024-06-30, the company held over 141.46 million shares (or 9.6337% of shares), all amounting to roughly $10.89 billion.
The next major institution holding the largest number of shares is VANGUARD GROUP INC with 129.87 million shares, or about 8.8444% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $10.0 billion.
